Skip to content

Testing a new Aloe vera moisturizer with probiotics to see how well it works and whether it causes any side effects

Development and Validation of BIOMOIST- Moisturizer from Aleovera Added with Probiotics. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099585
Enrollment
30
Registered
2025-12-22
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

Intervention1: BIOMOIST (Aloe vera based moisturizer with probiotics): Topical application of a moisturizer formulated using Aloe vera gel, Virgin coconut oil, and Lactobacillus rhamnosus (0.5%) appli

Sponsors

Saveetha medical college hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children aged between 6 months and 5 years with a clinical diagnosis of dermatitis considered suitable for topical therapy were eligible for inclusion. Only patients with limited disease involvement, defined as target lesions affecting not more than 10 percent of the total body surface area, were enrolled. Lesions were required to be located on the trunk or extremities. Written informed consent was obtained from the parent or legal guardian prior to inclusion in the study.

Exclusion criteria

Exclusion criteria: Children with a known history of hypersensitivity to Aloe vera, probiotics, or any of the formulation excipients were excluded. Patients presenting with infected, ulcerated, or actively weeping skin lesions were not considered for enrolment. Those with severe chronic dermatological conditions requiring systemic therapy, as well as children receiving systemic corticosteroids or other immunosuppressive medications, were also excluded from the study.

Design outcomes

Primary

MeasureTime frame
Reduction in pruritus score Improvement in skin condition score (SCORAD)Timepoint: baseline and after 4 weeks

Secondary

MeasureTime frame
Improvement in sleep quality, Caregiver satisfaction, Treatment adherenceTimepoint: Baseline and after 4 weeks

Countries

India

Contacts

Public ContactDr Akash

Saveetha medical college hospital

navinu.smc@saveetha.com9487002379

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026